| ID | Sequence | Length | GC content |
|---|---|---|---|
| LINC01480:23 | AGAGCAGAUCUUGGACUGAGACCUACAGGACACAGCGACUCUUAAAUAG… | 409 nt | 0.5379 |
| LINC01480:24 | AGAGCAGAUCUUGGACUGAGACCUACAGGACACAGGUACUGCUUUUUCU… | 522 nt | 0.4770 |
| LINC01480:3 | UAUCAGCAGGGUAAACACACAACCCACAGUAUAGGAAACAGUAGUCACA… | 749 nt | 0.4673 |
| LINC01480:4 | AUGUUAGUGGAAUUAACAUAUGCCCCACCCCAAGUGACUUCUAAAGGGC… | 467 nt | 0.5332 |
| LINC01480:5 | AUGUUAGUGGAAUUAACAUAUGCCCCACCCCAAGUGACUUCUAAAGGGC… | 478 nt | 0.5272 |
| LINC01480:6 | AGAGCAGAUCUUGGACUGAGACCUACAGGACACAGCGACUCUUAAAUAG… | 409 nt | 0.5379 |
| LINC01480:7 | CUCAAACCACAAUCACAGUUGUUGGUUCCAGAAACAUCUUCUUUGGAAA… | 580 nt | 0.4431 |
| LINC01480:8 | GGACAAUCCAGUCACGCAGAACUGACAAAACCUUGUCCAGUAAGAAGGU… | 594 nt | 0.4512 |
No relevant information is available at the moment.
A review of the literature indicates that the LINC01480 AC006129.1 is a long non-coding RNA identified as a therapeutic target in schizophrenia, where it functions by targeting SOCS3 and CASP1 [Das et al. DOI:10.1080/21655979.2021.2003667].